• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “sigstr” Archives

          in
          Entry Author Date Location
          Sigstr Snags $4M Funding Round as Marketing Tech Sector Gets Hotter Sarah Schmid Stevenson 09/21/18 Indiana
          Sigstr Launches Relationship Intelligence Platform for Corporate E-mail Sarah Schmid Stevenson 08/08/18 Indiana
          High Alpha Raises $100M+ for Two New Funds, Adds Brad Feld to Board Sarah Schmid Stevenson 07/16/18 Indiana
          Marketing Startup Sigstr Gets $5M From Hyde Park, HubSpot & Others Jeff Bauter Engel 08/22/17 Indiana
          HubSpot Dips Toe Further Into Startup Investing With Sigstr Deal Jeff Bauter Engel 08/22/17 Boston
          Sigstr Aims to Unlock the Marketing Potential of E-mail Signatures Sarah Schmid Stevenson 03/16/17 Indiana
          Sigstr Secures $500,000 New Funding VentureDeal 10/26/16 Indiana
          ExactTarget Alums Aim Big With Indianapolis Startup Studio High Alpha Jeff Bauter Engel 04/06/16 Indiana
          Sigstr Lands $1,500,000 New Financing Round VentureDeal 12/09/15 Indiana
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

            Sponsored · Whitepaper

            The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace

            Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars

            IBM Watson
          • How to Approach Life Sciences Fundraising

            Sponsored · Whitepaper

            How to Approach Life Sciences Fundraising

            Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research

            Brex
          • Decentralized Clinical Trials: The Call for a New Paradigm

            Sponsored · Whitepaper

            Decentralized Clinical Trials: The Call for a New Paradigm

            Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications

            PRA Health Sciences

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2022, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.